{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:26:55Z","timestamp":1793914015076,"version":"4.8.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.gene.2026.150044","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T08:02:20Z","timestamp":1770796940000},"page":"150044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Decoding testicular germ cell tumors: integrating risk, biology, and biomarkers into future care"],"prefix":"10.1016","volume":"988","author":[{"given":"Gartrell C.","family":"Bowling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Charles A.","family":"Lacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea A.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongeun","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Chesnut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig R.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8753-5726","authenticated-orcid":false,"given":"Sean Q.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2026.150044_b0005","doi-asserted-by":"crossref","unstructured":"Abughanimeh, O., Teply, B.A. Current management of refractory germ cell tumors. Curr. Oncol. Rep. 2021;23(9):101. doi:10.1007\/s11912-021-01093-z.","DOI":"10.1007\/s11912-021-01093-z"},{"issue":"1","key":"10.1016\/j.gene.2026.150044_b0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/annonc\/mdx680","article-title":"Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206","volume":"29","author":"Adra","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.gene.2026.150044_b0015","doi-asserted-by":"crossref","unstructured":"Almeida, A.A., Wojt, A., Metayer, C., et al. Racial\/ethnic differences in trends of testicular germ cell tumor incidence in the United States, 1992-2021. Cancer. 2025;131(2):e35706. doi:10.1002\/cncr.35706.","DOI":"10.1002\/cncr.35706"},{"issue":"5","key":"10.1016\/j.gene.2026.150044_b0020","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/j.juro.2009.07.045","article-title":"Clinicopathological study of regressed testicular tumors (apparent extragonadal germ cell neoplasms)","volume":"182","author":"Angulo","year":"2009","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.gene.2026.150044_b0025","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s00330-019-06495-z","article-title":"Radiomics allows for detection of benign and malignant histopathology in patients with metastatic testicular germ cell tumors prior to post-chemotherapy retroperitoneal lymph node dissection","volume":"30","author":"Baessler","year":"2020","journal-title":"Eur. Radiol."},{"issue":"3","key":"10.1016\/j.gene.2026.150044_b0030","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK-25-472654","article-title":"Key updates in testicular cancer: optimizing survivorship and survival","volume":"45","author":"Bagrodia","year":"2025","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"4_suppl","key":"10.1016\/j.gene.2026.150044_b0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1200\/JCO.2024.42.4_suppl.499","article-title":"Longitudinal tumor-informed ctDNA assay and patient outcomes in testicular cancer","volume":"42","author":"Ben-David","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.gene.2026.150044_b0040","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.eururo.2017.09.025","article-title":"Testicular tumour size and rete testis invasion as prognostic factors for the risk of relapse of clinical stage I seminoma testis patients under surveillance: a systematic review by the testicular cancer guidelines panel","volume":"73","author":"Boormans","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.gene.2026.150044_b0045","doi-asserted-by":"crossref","unstructured":"Chen, Y., Xie, Y., Ci H, et al. Plasma metabolites and risk of seven cancers: a two-sample Mendelian randomization study among European descendants. BMC Med. Mar 4 2024;22(1):90. doi:10.1186\/s12916-024-03272-8.","DOI":"10.1186\/s12916-024-03272-8"},{"issue":"6","key":"10.1016\/j.gene.2026.150044_b0050","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/ije\/dyq120","article-title":"A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer\u2013experiences of the son","volume":"39","author":"Cook","year":"2010","journal-title":"Int. J. Epidemiol."},{"issue":"18","key":"10.1016\/j.gene.2026.150044_b0055","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMra1706174","article-title":"Application of cell-free DNA analysis to cancer treatment","volume":"379","author":"Corcoran Ryan","year":"2018","journal-title":"New England J. Med."},{"key":"10.1016\/j.gene.2026.150044_b0060","doi-asserted-by":"crossref","unstructured":"De Felici, M., Klinger, F.G., Campolo, F., Balistreri CR, Barchi M, Dolci S. To be or not to be a germ cell: the extragonadal germ cell tumor paradigm. Int. J. Mol. Sci. 2021;22(11) 10.3390\/ijms22115982.","DOI":"10.3390\/ijms22115982"},{"issue":"1","key":"10.1016\/j.gene.2026.150044_b0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11764-022-01315-8","article-title":"Ototoxicity prognostic models in adult and pediatric cancer patients: a rapid review","volume":"17","author":"DeBacker","year":"2023","journal-title":"J. Cancer Surviv."},{"issue":"2","key":"10.1016\/j.gene.2026.150044_b0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eururo.2016.07.029","article-title":"Serum levels of MicroRNA miR-371a-3p: a sensitive and specific new biomarker for germ cell tumours","volume":"71","author":"Dieckmann","year":"2017","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.gene.2026.150044_b0075","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1093\/ije\/dyac194","article-title":"Cohort profile: the Danish blood donor study","volume":"52","author":"Erikstrup","year":"2023","journal-title":"Int. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.gene.2026.150044_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020428","article-title":"The immune landscape and immunotherapeutic strategies in platinum-refractory testicular germ cell tumors","volume":"16","author":"Evmorfopoulos","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"32","key":"10.1016\/j.gene.2026.150044_b0085","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1200\/JCO.21.01984","article-title":"Testicular cancer survivorship: looking back to move forward","volume":"39","author":"Fung","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.gene.2026.150044_b0090","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1158\/1055-9965.EPI-20-0107","article-title":"Increasing incidence of testicular germ cell tumors among racial\/ethnic minorities in the United States","volume":"29","author":"Ghazarian","year":"2020","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.gene.2026.150044_b0095","doi-asserted-by":"crossref","unstructured":"Ghosh, A., Sirinukunwattana, K., Khalid Alham N, et al. The potential of artificial intelligence to detect lymphovascular invasion in testicular cancer. Cancers (Basel). 2021;13(6)doi:10.3390\/cancers13061325.","DOI":"10.3390\/cancers13061325"},{"issue":"2","key":"10.1016\/j.gene.2026.150044_b0100","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1677\/ERC-09-0254","article-title":"Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype","volume":"17","author":"Greene","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"issue":"5","key":"10.1016\/j.gene.2026.150044_b0105","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.eururo.2019.07.002","article-title":"International trends in the incidence of testicular cancer: lessons from 35 years and 41 countries","volume":"76","author":"Gurney","year":"2019","journal-title":"Eur. Urol."},{"issue":"4_suppl","key":"10.1016\/j.gene.2026.150044_b0110","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.2024.42.4_suppl.500","article-title":"Utility of circulating tumor DNA (ctDNA) as a predictive biomarker for disease monitoring in patients with non-seminomatous germ-cell tumor (NSGCT)","volume":"42","author":"Hassoun","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"16_suppl","key":"10.1016\/j.gene.2026.150044_b0115","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1200\/JCO.2024.42.16_suppl.5037","article-title":"Post chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic pure seminoma","volume":"42","author":"Heidenreich","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gene.2026.150044_b0120","doi-asserted-by":"crossref","unstructured":"Hom, M., Sriprasert, I., Ihenacho, U., et al. Systematic review and meta-analysis of testicular germ cell tumors following in utero exposure to diethylstilbestrol. JNCI Cancer Spectr. 2019;3(3):pkz045. doi:10.1093\/jncics\/pkz045.","DOI":"10.1093\/jncics\/pkz045"},{"issue":"6","key":"10.1016\/j.gene.2026.150044_b0125","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/ohn.222","article-title":"Systematic review and meta-analysis of the influence of genetic variation on ototoxicity in platinum-based chemotherapy","volume":"168","author":"Hong","year":"2023","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"5","key":"10.1016\/j.gene.2026.150044_b0130","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.euo.2022.06.009","article-title":"Worldwide distribution, risk factors, and temporal trends of testicular cancer incidence and mortality: a global analysis","volume":"5","author":"Huang","year":"2022","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.gene.2026.150044_b0135","doi-asserted-by":"crossref","unstructured":"Kardoust Parizi, M., Singla, N., Daneshmand S, et al. Diagnostic efficacy of serum microRNAs in predicting pathology of retroperitoneal lymph node dissection in patients with testicular germ cell tumors: a systematic review and meta-analysis. World J Urol. 2025;43(1):192. doi:10.1007\/s00345-025-05571-y.","DOI":"10.1007\/s00345-025-05571-y"},{"issue":"5","key":"10.1016\/j.gene.2026.150044_b0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41568-022-00441-w","article-title":"CRISPR in cancer biology and therapy","volume":"22","author":"Katti","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.gene.2026.150044_b0145","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.21037\/tau-20-1349","article-title":"The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens","volume":"10","author":"Kremer","year":"2021","journal-title":"Transl. Androl. Urol."},{"issue":"2","key":"10.1016\/j.gene.2026.150044_b0150","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2019.10.005","article-title":"Serum MicroRNA-371a-3p levels predict viable germ cell tumor in chemotherapy-na\u00efve patients undergoing retroperitoneal lymph node dissection","volume":"77","author":"Lafin","year":"2020","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.gene.2026.150044_b0155","first-page":"3","article-title":"Metabolic fingerprinting of serum and seminal plasma of testicular cancer patients using raman spectroscopy: a pilot study","volume":"25","author":"Lakpour","year":"2024","journal-title":"J. Reprod. Infertil."},{"issue":"2","key":"10.1016\/j.gene.2026.150044_b0160","first-page":"403","article-title":"Cohort profile: the janus serum bank cohort in Norway","volume":"46","author":"Langseth","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.gene.2026.150044_b0165","doi-asserted-by":"crossref","unstructured":"Lisson, C.S., Manoj, S., Wolf, D., et al. Radiomics and clinicopathological characteristics for predicting lymph node metastasis in testicular cancer. Cancers (Basel). 2023;15(23)doi:10.3390\/cancers15235630.","DOI":"10.3390\/cancers15235630"},{"key":"10.1016\/j.gene.2026.150044_b0170","doi-asserted-by":"crossref","unstructured":"Litchfield, K., Thomsen, H., Mitchell, J.S., et al. Quantifying the heritability of testicular germ cell tumour using both population-based and genomic approaches. Sci Rep. 2015;5:13889. doi:10.1038\/srep13889.","DOI":"10.1038\/srep13889"},{"issue":"6","key":"10.1016\/j.gene.2026.150044_b0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrurol.2012.61","article-title":"Adolescent and adult risk factors for testicular cancer","volume":"9","author":"McGlynn","year":"2012","journal-title":"Nat. Rev. Urol."},{"issue":"2","key":"10.1016\/j.gene.2026.150044_b0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/PAP.0b013e31803240e6","article-title":"Extragonadal germ cell tumors: a review with emphasis on pathologic features, clinical prognostic variables, and differential diagnostic considerations","volume":"14","author":"McKenney","year":"2007","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.gene.2026.150044_b0185","doi-asserted-by":"crossref","unstructured":"Messerlian, C., Williams, P.L., Ford, J.B., et al. The environment and reproductive health (EARTH) study: a prospective preconception cohort. Hum. Reprod. Open. 2018;2018(2)doi:10.1093\/hropen\/hoy001.","DOI":"10.1093\/hropen\/hoy001"},{"issue":"2","key":"10.1016\/j.gene.2026.150044_b0190","doi-asserted-by":"crossref","first-page":"178","DOI":"10.21873\/cgp.20313","article-title":"MicroRNAs in differentiation of embryoid bodies and the teratoma subtype of testicular cancer","volume":"19","author":"Myklebust","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"issue":"1","key":"10.1016\/j.gene.2026.150044_b0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2020.10.024","article-title":"Integrated expression of circulating miR375 and miR371 to identify teratoma and active germ cell malignancy components in malignant germ cell tumors","volume":"79","author":"Nappi","year":"2021","journal-title":"Eur. Urol."},{"key":"10.1016\/j.gene.2026.150044_b0200","doi-asserted-by":"crossref","unstructured":"Nestler, T., Schoch, J., Belge, G., Dieckmann, K.P. MicroRNA-371a-3p-the novel serum biomarker in testicular germ cell tumors. Cancers (Basel). 2023;15(15)doi:10.3390\/cancers15153944.","DOI":"10.3390\/cancers15153944"},{"issue":"4","key":"10.1016\/j.gene.2026.150044_b0205","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/cncr.34571","article-title":"Differentially expressed messenger RNA\/proteins can distinguish teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection tissue","volume":"129","author":"Nestler","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.gene.2026.150044_b0210","doi-asserted-by":"crossref","unstructured":"Ni Leathlobhair, M., Frangou, A., Kinnersley, B., et al. Genomic landscape of adult testicular germ cell tumours in the 100,000 Genomes Project. Nat Commun. Oct 26 2024;15(1):9247. doi:10.1038\/s41467-024-53193-6.","DOI":"10.1038\/s41467-024-53193-6"},{"key":"10.1016\/j.gene.2026.150044_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103224","article-title":"Serum tumour markers in germ cell tumours: from diagnosis to cure","volume":"159","author":"Pedrazzoli","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"10 Suppl","key":"10.1016\/j.gene.2026.150044_b0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7205\/MILMED-D-14-00739","article-title":"A brief description of the operation of the DoD serum repository","volume":"180","author":"Perdue","year":"2015","journal-title":"Mil. Med."},{"key":"10.1016\/j.gene.2026.150044_b0225","doi-asserted-by":"crossref","unstructured":"Pluta, J., Pyle, L.C., Nead, K.T., et al. Identification of 22 susceptibility loci associated with testicular germ cell tumors. Nat. Commun., 2021;12(1):4487. doi:10.1038\/s41467-021-24334-y.","DOI":"10.1038\/s41467-021-24334-y"},{"issue":"4","key":"10.1016\/j.gene.2026.150044_b0230","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.eururo.2023.05.008","article-title":"Germline exome sequencing for men with testicular germ cell tumor reveals coding defects in chromosomal segregation and protein-targeting genes","volume":"85","author":"Pyle","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.gene.2026.150044_b0235","doi-asserted-by":"crossref","unstructured":"Scavuzzo, A., Pasini, G., Crescio, E., et al. Radiomics analyses to predict histopathology in patients with metastatic testicular germ cell tumors before post-chemotherapy retroperitoneal lymph node dissection. J. Imaging. Oct 7 2023;9(10)doi:10.3390\/jimaging9100213.","DOI":"10.3390\/jimaging9100213"},{"issue":"6","key":"10.1016\/j.gene.2026.150044_b0240","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/FTD.0000000000001113","article-title":"Systematic critical review of genetic factors associated with cisplatin-induced ototoxicity: Canadian pharmacogenomics network for drug safety 2022 update","volume":"45","author":"Scott","year":"2023","journal-title":"Ther. Drug Monit."},{"issue":"11","key":"10.1016\/j.gene.2026.150044_b0245","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.celrep.2018.05.039","article-title":"Integrated Molecular characterization of testicular germ cell tumors","volume":"23","author":"Shen","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.gene.2026.150044_b0250","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.gene.2026.150044_b0255","doi-asserted-by":"crossref","first-page":"642.e1","DOI":"10.1016\/j.urolonc.2020.03.013","article-title":"Incident testicular cancer in relation to using marijuana and smoking tobacco: a systematic review and meta-analysis of epidemiologic studies","volume":"38","author":"Song","year":"2020","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.gene.2026.150044_b0260","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program. Testis SEER 5-Year Relative Survival Rates. Accessed 01 May 2025. www.seer.cancer.gov. Accessed 01 May 2025. www.seer.cancer.gov."},{"issue":"32","key":"10.1016\/j.gene.2026.150044_b0265","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1200\/JCO.22.00118","article-title":"Primary retroperitoneal lymph node dissection for patients with pathologic stage ii nonseminomatous germ cell tumor-N1, N2, and N3 disease: is adjuvant chemotherapy necessary?","volume":"40","author":"Tachibana","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.gene.2026.150044_b0270","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.eururo.2024.10.023","article-title":"Epidemiology and risk factors for testicular cancer: a systematic review","volume":"87","author":"Tateo","year":"2025","journal-title":"Eur. Urol."},{"issue":"8","key":"10.1016\/j.gene.2026.150044_b0275","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/ijc.28207","article-title":"Congenital malformations and testicular germ cell tumors","volume":"133","author":"Trabert","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"6444","key":"10.1016\/j.gene.2026.150044_b0280","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1126\/science.aaw6985","article-title":"Cancer modeling meets human organoid technology","volume":"364","author":"Tuveson","year":"2019","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.gene.2026.150044_b0285","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ajhg.2025.01.022","article-title":"Identification of genes associated with testicular germ cell tumor susceptibility through a transcriptome-wide association study","volume":"112","author":"Ugalde-Morales","year":"2025","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.gene.2026.150044_b0290","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.cell.2006.02.037","article-title":"A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors","volume":"124","author":"Voorhoeve","year":"2006","journal-title":"Cell"}],"updated-by":[{"DOI":"10.1016\/j.gene.2026.150440","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:00:00Z","timestamp":1792972800000}},{"DOI":"10.1016\/j.gene.2026.150440","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2027,1,10]],"date-time":"2027-01-10T00:00:00Z","timestamp":1799539200000}}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:12:35Z","timestamp":1771823555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111926000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":58,"alternative-id":["S0378111926000533"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2026.150044","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding testicular germ cell tumors: integrating risk, biology, and biomarkers into future care","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2026.150044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"150044"}}